Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 1996;55:248-252; doi:10.1136/ard.55.4.248
Copyright © 1996 BMJ Publishing Group Ltd & European League Against Rheumatism.

Impaired activity of protease inhibitors towards neutrophil elastase bound to human articular cartilage.

K Kawabata, A R Moore, D A Willoughby

Department of Experimental Pathology, William Harvey Research Institute, St Bartholomew's Hospital Medical College, London, United Kingdom.

OBJECTIVE: To investigate the effects of protease inhibitors on the ability of free and cartilage bound neutrophil elastase to degrade cartilage proteoglycan in vitro. METHODS: Cryostat sections of human articular cartilage were used as substrate, and proteoglycan loss induced by free or cartilage bound elastase was quantified by alcian blue staining, followed by scanning and integrating microdensitometry. RESULTS: High molecular mass protease inhibitors (alpha 1 protease inhibitor, alpha 2 macroglobulin, and soya bean trypsin inhibitor) and synovial fluid from patients with rheumatoid arthritis were effective in blocking proteoglycan loss from sections treated with free elastase, but their activity towards cartilage bound elastase was much reduced. In contrast, low molecular mass elastase inhibitors (N-methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone and ONO-5046 (N-[2-[4-(2,2-dimethylpropionyloxy) phenylsulphonylamino]benzoyl] amino-acetic acid) were effective against free and cartilage bound elastase. CONCLUSION: The binding of elastase to cartilage appears to be a mechanism whereby the enzyme can remain active in the presence of high molecular mass protease inhibitors.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Morimoto, N., Morimoto, K., Morimoto, Y., Takahashi, H., Asano, M., Matsumori, M., Okada, K., Okita, Y. (2008). Sivelestat attenuates postoperative pulmonary dysfunction after total arch replacement under deep hypothermia. Eur. J. Cardiothorac. Surg. 34: 798-804 [Abstract] [Full Text]  
  • Matsuzaki, K., Hiramatsu, Y., Homma, S., Sato, S., Shigeta, O., Sakakibara, Y. (2005). Sivelestat Reduces Inflammatory Mediators and Preserves Neutrophil Deformability During Simulated Extracorporeal Circulation. Ann. Thorac. Surg. 80: 611-617 [Abstract] [Full Text]  
  • KAWABATA, K., HAGIO, T., MATSUMOTO, S., NAKAO, S., ORITA, S., AZE, Y., OHNO, H. (2000). Delayed Neutrophil Elastase Inhibition Prevents Subsequent Progression of Acute Lung Injury Induced by Endotoxin Inhalation in Hamsters. Am. J. Respir. Crit. Care Med. 161: 2013-2018 [Abstract] [Full Text]  
  • Yamazaki, T., Ooshima, H., Usui, A., Watanabe, T., Yasuura, K. (1999). Protective effects of ONO-5046{middle dot}Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury. Ann. Thorac. Surg. 68: 2141-2146 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs